Redistribution, Homing and Organ-Invasion of Neoplastic Stem Cells in Myeloid Neoplasms
Standard
Redistribution, Homing and Organ-Invasion of Neoplastic Stem Cells in Myeloid Neoplasms. / Valent, Peter; Sadovnik, Irina; Eisenwort, Gregor; Herrmann, Harald; Bauer, Karin; Mueller, Niklas; Sperr, Wolfgang R; Wicklein, Daniel; Schumacher, Udo.
in: SEMIN CANCER BIOL, Jahrgang 60, 02.2020, S. 191-201.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Redistribution, Homing and Organ-Invasion of Neoplastic Stem Cells in Myeloid Neoplasms
AU - Valent, Peter
AU - Sadovnik, Irina
AU - Eisenwort, Gregor
AU - Herrmann, Harald
AU - Bauer, Karin
AU - Mueller, Niklas
AU - Sperr, Wolfgang R
AU - Wicklein, Daniel
AU - Schumacher, Udo
N1 - Copyright © 2019 Elsevier Ltd. All rights reserved.
PY - 2020/2
Y1 - 2020/2
N2 - The development of a myeloid neoplasm is a step-wise process that originates from leukemic stem cells (LSC) and includes pre-leukemic stages, overt leukemia and a drug-resistant terminal phase. Organ-invasion may occur in any stage, but is usually associated with advanced disease and a poor prognosis. Sometimes, extra-medullary organ invasion shows a metastasis-like or even sarcoma-like destructive growth of neoplastic cells in local tissue sites. Examples are myeloid sarcoma, mast cell sarcoma and localized blast phase of chronic myeloid leukemia. So far, little is known about mechanisms underlying re-distribution and extramedullary dissemination of LSC in myeloid neoplasms. In this article, we discuss mechanisms through which LSC can mobilize out of the bone marrow niche, can transmigrate from the blood stream into extramedullary organs, can invade local tissue sites and can potentially create or support the formation of local stem cell niches. In addition, we discuss strategies to interfere with LSC expansion and organ invasion by targeted drug therapies.
AB - The development of a myeloid neoplasm is a step-wise process that originates from leukemic stem cells (LSC) and includes pre-leukemic stages, overt leukemia and a drug-resistant terminal phase. Organ-invasion may occur in any stage, but is usually associated with advanced disease and a poor prognosis. Sometimes, extra-medullary organ invasion shows a metastasis-like or even sarcoma-like destructive growth of neoplastic cells in local tissue sites. Examples are myeloid sarcoma, mast cell sarcoma and localized blast phase of chronic myeloid leukemia. So far, little is known about mechanisms underlying re-distribution and extramedullary dissemination of LSC in myeloid neoplasms. In this article, we discuss mechanisms through which LSC can mobilize out of the bone marrow niche, can transmigrate from the blood stream into extramedullary organs, can invade local tissue sites and can potentially create or support the formation of local stem cell niches. In addition, we discuss strategies to interfere with LSC expansion and organ invasion by targeted drug therapies.
KW - Animals
KW - Biomarkers
KW - Bone Marrow/pathology
KW - Cell Communication
KW - Cell Movement
KW - Humans
KW - Immunophenotyping
KW - Leukemia, Myeloid/etiology
KW - Neoplasm Staging
KW - Neoplastic Stem Cells/metabolism
KW - Phenotype
KW - Recurrence
KW - Transendothelial and Transepithelial Migration/genetics
KW - Tumor Microenvironment/genetics
U2 - 10.1016/j.semcancer.2019.07.025
DO - 10.1016/j.semcancer.2019.07.025
M3 - SCORING: Review article
C2 - 31408723
VL - 60
SP - 191
EP - 201
JO - SEMIN CANCER BIOL
JF - SEMIN CANCER BIOL
SN - 1044-579X
ER -